Rheumatology/Arthritis Market Research Reports & Industry Analysis
Some evidence suggests that excessive immune responses may be due to glucocorticoid resistance in target tissues. For example, the number of glucocorticoid receptors in circulating leukocytes is decreased 50% in patients with RA. This decrease in receptors would prevent adequate suppression of leukocyte activity and could further enhance inflammation.Rheumatologists remain the most up-to-date health professionals in autoimmune disease treatment. Early intervention has been noted by nearly all in the field as the single most important factor in treatments and continued quality of life. New advancements in risk factors, diagnosis, and therapies have made it possible for rheumatologist to treat these conditions successfully with the best possible outcomes.
Successful treatment of autoimmune diseases have resulted from a growing array of therapies available to specialists. Symptomatic treatments have traditionally been used for patients with rheumatoid arthritis, lupus and other autoimmune disorders. While these treatments are still used regularly, new disease-modifying therapies have produced the most impressive results in treating these diseases. Additionally, combination therapies continue to grow in preference and offer exciting results in disease management.
Rheumatology/Arthritis Industry Research & Market Reports
-
Global Meloxicam Market Size study, by Diseases (Osteoarthritis, Rheumatoid Arthritis, Juvenile Rheumatoid Arthritis, Others) by Drug Type (Generic, Branded) by Population Type (Adult, Children) by Dosage (Oral, Parenteral, transdermal, Others) by Dose Strength (7.5mg, 15mg, Others) by End-Users (Hospitals, Specialty Clinics, Home Healthcare, Others) by Distribution Channel (Direct Tender, Hospital Pharmacy, Retail Pharmacy, Online Pharmacy, Others) and Regional Forecasts 2022-2028
... Others) by End-Users (Hospitals, Specialty Clinics, Home Healthcare, Others) by Distribution Channel (Direct Tender, Hospital Pharmacy, Retail Pharmacy, Online Pharmacy, Others) and Regional Forecasts 2022-2028Global Meloxicam Market is valued approximately USD XX billion in 2021 ... Read More
-
Prefilled Syringes Market by Material (Glass-based and Plastic-based), Design (Single-chamber Prefilled Syringes, Dual-chamber Prefilled Syringes, and Customized Prefilled Syringes), Therapeutic (Large Molecules and Small Molecules), and Application (Anaphylaxis, Rheumatoid Arthritis, Diabetes, and Others (Cancer, Multiple Sclerosis and Others)): Global Opportunity Analysis and Industry Forecast, 2021–2030
... Sclerosis and Others)): Global Opportunity Analysis and Industry Forecast, 2021–2030 The global prefilled syringes market was valued at $5,620.23 million in 2020, and is projected to reach $15,735.49 million by 2030, registering a CAGR of ... Read More
-
Global Non-oncology Biopharmaceuticals Market - 2021-2028
... of XX % during the forecast period (2021-2028). Biopharmaceuticals are part of the wider category of therapeutic agents called biologics. Biopharmaceuticals are substances developed in living systems with the help of biotechnology and are used ... Read More
-
C-Reactive Protein Testing Market by Assay Type (Enzyme-Linked Immunosorbent Assay (ELISA), Chemiluminescence Immunoassay (CLIA), Immunoturbidimetric Assay, and Others) and Application (Diabetes, Rheumatoid Arthritis, Cardiovascular Disease, Inflammatory Bowel Disease, and Others): Global Opportunity Analysis and Industry Forecast, 2021–2030
... Forecast, 2021–2030 The global c-reactive protein testing market was valued at $2,765.07 million in 2020, and is estimated to reach $3,568.69 million by 2030, growing at a CAGR of 2.4% from 2021 to 2030. C-reactive ... Read More
-
Chronic Lower Back Pain (CLBP) - Market Insight, Epidemiology And Market Forecast - 2032
... States, EU5 (Germany, France, Italy, Spain, and the United Kingdom) and Japan. The CLBP market report provides current treatment practices, emerging drugs, and market share of the individual therapies, current and forecasted 7MM CLBP market ... Read More
-
Rheumatoid Arthritis Drugs Market, Size, Share, Global Forecast 2022-2027, Industry Trends, Impact of COVID-19, Opportunity Company Analysis
... that induces pain and inflammation in joints. It influences individuals of all ages; notwithstanding, the geriatric population is highly susceptible to developing this disorder. The symptoms of rheumatoid arthritis embrace pain, stiffness, tenderness, and swelling ... Read More
-
Rheumatoid Arthritis - Market Insight, Epidemiology and Market Forecast -2032
... States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan. The Rheumatoid Arthritis market report provides current treatment practices, emerging drugs, Rheumatoid Arthritis market share of the individual therapies, current and forecasted Rheumatoid Arthritis ... Read More
-
Juvenile Rheumatoid Arthritis - Epidemiology Forecast to 2032
... Spain, Italy, France, and the United Kingdom), and Japan. Geographies Covered • The United States • EU5 (Germany, France, Italy, Spain, and the United Kingdom) • Japan Study Period: 2019-2032 Juvenile Rheumatoid Arthritis Understanding The ... Read More
-
Rheumatoid Arthritis (RA) - Epidemiology Forecast to 2032
... Spain, Italy, France, and the United Kingdom), and Japan. Geographies Covered • The United States • EU5 (Germany, France, Italy, Spain, and the United Kingdom) • Japan Study Period: 2019-2032 Rheumatoid Arthritis (RA) Understanding The ... Read More
-
Stem Cell Therapy Market- By Cell Source (Adipose Tissue-Derived Mesenchymal SCs, Bone Marrow-Derived Mesenchymal SCs, And Embryonic SCs), By Type (Allogenic SCs And Autologous SCs), By End-User (ASCs And Hospitals), And By Therapeutic Application (Musculoskeletal Disorders, Wounds & Injuries, Cardiovascular Diseases, Gastrointestinal Diseases, And Immune System Diseases): Global Industry Perspective, Comprehensive Analysis, And Forecast, 2021–2030
... Disorders, Wounds & Injuries, Cardiovascular Diseases, Gastrointestinal Diseases, And Immune System Diseases): Global Industry Perspective, Comprehensive Analysis, And Forecast, 2021–2030 Market Overview Fatpos Global has released a report titled Stem Cell Therapy Market - Analysis ... Read More
-
Global Rheumatic Disorders Drugs Market to 2024 - Increased Uptake of IL Inhibitors and JAK Inhibitors to Drive Growth as TNF Inhibitors Face Patent Expiry
... are characterized by chronic pain, with some of the most common conditions being osteoarthritis (OA) and rheumatoid arthritis (RA), and it is estimated that about one in four adults in America are diagnosed with a ... Read More
Research Assistance
